Jiwon Song

Title: Jiwon Song: Innovator in 3D-Printed Biocompatible Devices

Introduction

Jiwon Song is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of innovative devices for cell transplantation. Her work focuses on creating solutions that enhance the viability and functionality of stem cell therapies.

Latest Patents

Jiwon Song holds a patent for a groundbreaking invention titled "3D-printed scaffold device for cell transplantation." This patent describes a 3D-printed, biocompatible macroporous device designed to house stem cell-derived β-cell (SC-β cell) clusters within a degradable fibrin gel. The invention addresses the challenge of severe hypoxia within 3D-printed devices by utilizing cluster sizes that avoid this issue. Additionally, a microwell-based technique is employed for resizing clusters to optimal dimensions. The 3D-printed devices are designed to function for at least 12 weeks, are retrievable, and maintain their structural integrity throughout their use.

Career Highlights

Jiwon Song is affiliated with Washington University, where she continues to advance her research and innovation in the field of biomedical devices. Her work has garnered attention for its potential to improve outcomes in cell transplantation therapies.

Collaborations

Jiwon collaborates with Jeffrey R. Millman, a fellow researcher in the field. Their partnership enhances the development and application of innovative solutions in regenerative medicine.

Conclusion

Jiwon Song is a trailblazer in the realm of 3D-printed biocompatible devices, with her patent showcasing her commitment to advancing medical technology. Her contributions are poised to make a significant impact on the future of cell transplantation therapies.